# Step 227 — Minimal owner-assisted authenticated acceptance

2026-10-28 (America/Toronto). **Normal owner-assisted sign-in succeeded. Acceptance remains incomplete because the authenticated directory search returned no active locations.** No functional failure was observed. No prescription or directory mutation was submitted.

## Authentication, tenant and fixture

Opened a separate visible Edge window using existing local browser tooling. The owner manually entered credentials and selected the development tenant. No seeded passwords or configuration credentials were read; no cookies/access tokens were extracted; no authentication configuration was changed or bypassed. No credentials were logged or stored by the acceptance tooling. The isolated browser was closed after the checks.

The authenticated application's `microemr-tenant-id` meta element contained **f94c6ecd-4417-483e-8a94-0507cf8384c2**, matching the established **local-dev-fresh** identity. The owner also confirmed that selection. No new SQL verification was performed.

The owner opened an existing disposable development prescription in the Patient Chart's **Edit Prescription Draft** modal. The form action was `/PatientPrescriptions/Edit`, with **Save Changes** available and the dispensing-location lookup visible. This was an unsigned Draft edit form, not a finalized prescription. The account had permitted prescribing lookup access; its named role and credentials were not inspected or recorded. Patient/clinical contents and fixture identifiers are omitted.

## Six minimum checks

| # | Check | Result | Live observation |
|---|---|---|---|
| 1 | Selected tenant is local-dev-fresh | PASS | Authenticated page tenant UID matched the established development identity; owner confirmed the selection. |
| 2 | Authorized user can open dispensing-location lookup | PASS | Lookup controls were visible within the unsigned Draft edit form. Its normal same-origin search request was accepted with HTTP 200. |
| 3 | Search for or select an existing dispensing location | BLOCKED | Clicked **Search locations** once with an empty search term. `/DispensingLocations/Lookup` returned HTTP 200; the rendered status was **No matching active locations.**, with zero result buttons. Search executed successfully, but no existing selectable entry was available to complete this check. |
| 4 | Retrieve selected identifier and associated details | BLOCKED | No selectable active entry; no detail request was submitted. |
| 5 | Save identifier to unsigned prescription and display it afterward | BLOCKED | No directory selection was available. No Save Changes request or prescription write was submitted. |
| 6 | Existing name/address values are not silently overwritten | BLOCKED | The chosen Draft's name/address inputs were blank. No selection was possible, so overwrite behavior could not be exercised. No temporary test values were entered and no fields were changed. |

**Totals: PASS 2 / FAIL 0 / BLOCKED 4 / NOT TESTED 0.** Blocked checks were not executed to completion and are not counted again as NOT TESTED. These are the six Step 227 checks only; the 27-scenario plan was not repeated.

Evidence is from the running authenticated browser UI and its normal same-origin lookup request. No direct API-only call, mock host or automated regression result was substituted for live UI acceptance. The HTTP 200 search response and empty rendered result do not prove successful directory detail resolution or prescription persistence.

## Blocker and scope boundary

The lookup supplied no active selectable location in the verified tenant. An empty directory result is a fixture/prerequisite blocker, not an established application defect. The underlying database contents were not independently enumerated. No maintenance operation or new directory entry was introduced to overcome the blocker; stopped the remaining dependent checks.

No finalized prescription was modified. No patient, prescription or directory data was created/edited, and no mutation audit outcome is claimed. No source-code change, migration, SQL permission change, backup/restore, service restart, credential extraction, build, broad regression run or Git mutation occurred. Security and isolation tests were not repeated.

Actual branch was **main**, unchanged. Pre-existing untracked reports 294–299 were preserved; the tracked diff stayed empty. Created only this report. The six existing report hashes were checked immediately before and after report creation and matched.

## Evidence reused and closure recommendation

Reused [Step 225](298-step225-de09-032-runtime-grants-execution.md): the three narrow directory EXECUTE permissions were verified, runtime principal **microemr_dev**, migrations **0098/0099 applied**. Reused Step 218 automated evidence: **473 backend/view cases PASS, 59 frontend cases PASS, isolated build and TypeScript checks PASS**. Reused [Step 226](299-step226-de09-032-authenticated-workflow-acceptance.md): Web/API/Auth reachable and prior acceptance blocked by unavailable approved authentication. Those checks were not rerun as a suite.

Step 227 resolves the owner-assisted authentication prerequisite and demonstrates permitted lookup access/search in the selected tenant. It does **not** establish selected-entry resolution, saved identifier display or absence of silent name/address overwrite. **Do not mark DE09.032 satisfied. Keep DE09.032 PARTIAL and PC07.01 PARTIAL; mandatory-gap inventory remains 7 IDs / 3 packages.** Retain the existing DE09.034/DE09.035 qualified closures; no certification inventory or closure file was changed.

**Recommended next step:** the owner identifies an existing active dispensing location available to this tenant's lookup, or explicitly authorizes provisioning one bounded development directory fixture through normal authorized maintenance. Then complete only the blocked selection/detail/save/display/no-overwrite checks in an owner-signed-in session, using the disposable unsigned Draft. Do not repeat the full acceptance plan or broad regressions. Review the resulting evidence before any DE09.032 closure decision.
